DFX Intelligence

Data Factory

Private creditBorrowerdrug discovery & developmentaunknown

AmplifyBio, LLC

sponsor (inference, pe portfolio stem): Viking Global Investors LP

Search this name across graphsid dfx:pc:981c4ba4-b5f3-18c6-3acf-545d978a22b1

Data as of Mar 31, 2025 (this record's last observation) from The BDC tape; Adviser-reported credit funds; Deal parties; Pending. Page built Sep 18, 2026, 11:01 PM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 9
On other graphs: 1
Observed: Dec 31, 2022 to Mar 31, 2025
2 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

AmplifyBio

name equal in sponsor portfolio · confidence 95% · family precision 100%

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Lenders: 1
BDCs: 1
Facilities: 2
Principal, latest: $22.5Mpieces as filed; a lower bound
Fair value, latest: $13.1M
Mark ratio: 56%fair value over cost, latest
Next maturity: Jan 1, 2027
First on a schedule: Dec 31, 2022
Last on a schedule: Mar 31, 2025
Sponsor basis: pe_portfolio_steminferencedeal party is a fact; a portfolio stem or a Form D signer is an inference

Facilities

one facility is one borrower, one kind and one lien; its size is the sum of the BDC pieces the tape can see, a lower bound, never the commitment

Kind	Lien	Size, lower bound	Fair value	Maturity	Maturity basis	Spread	PIK	Lenders	BDCs	Status	Last seen
Term loan	First lien	$22.5M	$13.1M	Jan 1, 2027	Ident text	0	n/a	1	1	Unknown	Mar 31, 2025
warrant	equity	n/a	$0	n/a	n/a	n/a	n/a	1	1	Unknown	Mar 31, 2025

Relationships

Sponsors (1)

← Viking Global Investors LPSponsor of borrowersPE portfolio stem
Sep 15, 2026 to presentinferenceDFX's own graph

Dated events

6 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Mar 31, 2025
Borrower left every BDC schedule
AmplifyBio, LLC term loan (first lien) left every BDC schedule after 2025-03-31 (1 lender, $22.5M last held)
BDC schedule of investments
$22.5M
Occurred
Mar 31, 2025
Marked down across lenders
AmplifyBio, LLC term loan: marked from 101 to 56 cents on cost across 1 lender(s)
BDC schedule of investments
$22.5M
Occurred
Mar 31, 2025
Marked down by a BDC
Hercules Capital, Inc.: fair value markdown in AmplifyBio, LLC (101 to 56 cents on cost)
BDC schedule of investmentsobserved 1.4 years ago
0.563298490127758 usd

Show 6 bookkeeping events

Occurred
Jun 30, 2025
Hercules Capital, Inc.: position exited in AmplifyBio, LLC ($22.5M principal)
Occurred
Jun 30, 2025
Hercules Capital, Inc.: position exited in AmplifyBio, LLC
Occurred
Mar 31, 2025
Hercules Capital, Inc.: principal decreased in AmplifyBio, LLC ($22.5M principal)
Occurred
Dec 31, 2024
Hercules Capital, Inc.: principal increased in AmplifyBio, LLC ($48.0M principal)
Occurred
Mar 31, 2024
Hercules Capital, Inc.: principal decreased in AmplifyBio, LLC ($24.0M principal)
Occurred
Dec 31, 2023
Hercules Capital, Inc.: principal increased in AmplifyBio, LLC ($48.0M principal)

Provenance

Graph: Private Credit
Canonical id: dfx:pc:981c4ba4-b5f3-18c6-3acf-545d978a22b1
First observed: Dec 31, 2022
Last observed: Mar 31, 2025 17 months ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

AmplifyBio, LLC

sponsor (inference, pe portfolio stem): Viking Global Investors LP

Search this name across graphsid dfx:pc:981c4ba4-b5f3-18c6-3acf-545d978a22b1

Kind

Lien

Size, lower bound

Fair value

Maturity

Maturity basis

Spread

PIK

Lenders

BDCs

Status

Last seen

Term loan

First lien

$22.5M

$13.1M

Jan 1, 2027

Ident text

n/a

Unknown

Mar 31, 2025

warrant

equity

n/a

Unknown

Mar 31, 2025